Brian J. Brille
At a glance: Brian J. Brille is See Remarks at Caris Life Sciences (CAI). Their latest SEC Form 4, filed Sep 17, 2026, reported a sale of $12.1M. On file: 0 purchase lines ($0) and 1 sale line ($12.1M).
Disclosed holdings: about $4.0M of CAI stock: 230,303 shares reported on their latest Form 4 (filed Sep 17, 2026), valued at the Nov 20, 2026 close of $17.57. This counts only CAI shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
See Remarks at Caris Life Sciences, Inc. (CAI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Brian J. Brille's InsiderPrint
2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (1)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | CAICaris Life Sciences, Inc. | Sell | 400,000230,303 held (−63%) | $30.33 | $12.1M | -42.1% |
- Sell
See Remarks Brian J Brille sold $12.1M of CAI at $30.33 — cuts the stake by 63%.
Follow Brian J. Brille
Get one email when Brian J. Brille files a new purchase or sale. Free.
At most one email a day about Brian J. Brille, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.